Home » Archives by category » Medical Device News
Nano Pulse Stimulation, bioelectric stimulation can treat skin lesions

Nano Pulse Stimulation, bioelectric stimulation can treat skin lesions

According to a new study published in the special issue of the journal Bioelectricity, most of the human diseases including skin lesions can be treated by applying bioelectrical impulses. The Nano-Pulse Stimulation (NPS) technique works by delivering nanosecond pulsed electric fields to cells and tissues. NPS specifically targets cells to generate nanometer wide pores and […]

Todos Medical to acquire in vitro diagnostics company Provista Diagnostics

Todos Medical acquisition of Provista Diagnostics : Israel-based Todos Medical signed an exclusive option agreement to acquire Provista Diagnostics,  an in vitro diagnostics company having a CLIA/CAP certified lab in Alpharetta, Georgia. Financial terms of the possible deal have not been disclosed. Todos Medical is an in-vitro diagnostics company engaged in developing blood tests for […]

Continue reading …
Element Biosciences raises $80m for genomic sequencing solutions

Californian biotechnology startup Element Biosciences, which focuses on developing genomic sequencing solutions for research and diagnostic markets, has raised $80.3 million in a Series B financing round. The financing round saw the entry of new investors Fidelity Management & Research and JS Capital alongside participation from existing investors Foresite Capital and Venrock. The US biotechnology startup […]

Continue reading …
ForaCare Suisse launches FOR A 6 GTel diabetes monitoring device

ForaCare Suisse has launched a new cellular multi-functional diabetes monitoring device FORA 6 GTel based on its Lab in the Pocket technology. The Lab in the Pocket technology, which has also been newly launched, is available on the GTel model and FOR A 6 Series products, said the Swiss healthcare technology company. According to ForaCare […]

Continue reading …
Biotricity completes development of Biopatch ECG patch platform

Biotricity said that it has wrapped up development of Biopatch, a new ECG patch platform for cardiac patients with fewer complications. The US medical technology company has developed the new ECG patch platform in a miniaturized form factor having three standard electrodes, with no lead wires. Biotricity is an extension of the company’s Bioflux device, […]

Continue reading …
Impulse Dynamics raises $80m to commercialize Optimizer Smart System

Impulse Dynamics, a US medical device company, has secured $80.25 million in a Series D financing round led by medical technology investor Amzak Health Investors for the commercialization of its Optimizer Smart System for heart failure. Optimizer Smart System is an implantable device which has been approved by the US Food and Drug Administration (FDA) […]

Continue reading …
Baxter to acquire Seprafilm Adhesion Barrier from Sanofi for $350m

Baxter International, a US-based health care company, has signed a deal worth $350 million to acquire Seprafilm Adhesion Barrier and related assets from French pharma company Sanofi, in a move to expand its advanced surgery portfolio. Seprafilm Adhesion Barrier is a medical device, which has FDA approval for preventing adhesion in patients going through abdominal […]

Continue reading …
LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection

Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus (QFT-Plus automated screening solution) on the latter’s LIAISON platforms for detecting latent tuberculosis (TB). With the FDA approval, Qiagen and Diasorin can perform laboratory automation for latent TB screening, which will support the conversion from tuberculin skin […]

Continue reading …
Genetron Health’s semiconductor-based NGS system gets Chinese approval

Genetron Health has been granted approval by China’s National Medical Products Administration (NMPA) for GENETRON S5, its semiconductor-based next-generation sequencing system (NGS system). With the approval, the Chinese precision oncology company can launch the new desktop medium-throughput NGS system for clinical applications. The NGS system has been developed by Genetron Health for the detection of […]

Continue reading …
LABORIE to acquire Clinical Innovations from EQT for $525m

LABORIE acquisition of Clinical Innovations : LABORIE Medical Technologies has agreed to acquire Utah-based Clinical Innovations for $525 million from EQT Mid Market US fund and the EQT Mid Market Asia III fund (jointly EQT). Headquartered in Salt Lake City, Clinical Innovations provides medical devices for the labor and delivery (L&D) and neonatal intensive care […]

Continue reading …
Page 1 of 7123Next ›Last »